Insulet Corporation announced a voluntary medical device correction for specific lots of Omnipod 5 Pods due to a manufacturing issue. The company expects costs up to $40 million in 2026 but maintains its guidance. 18 serious adverse events reported, no fatalities.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.